Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/603538 stock hub

SHA/603538 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/603538is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

15.1B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/603538

In the news

Latest news · SHA/603538

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 17.1P50 24.2P75 37.8

Trailing P/E127.4

P25 23.5P50 41.3P75 83.2

ROE4.8

P25 -0.9P50 4.1P75 8.8

ROIC5.8

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/603538 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

CNY

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	2,404
Enterprise value	CNY 15.9B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100002Y25
Last refreshed	2026-05-10
Market cap	CNY 15.1B
Price	CNY 63.7
Price currency	CNY
Rev Per Employee	632,803.64x
Sector	Healthcare
Sic	2834
Symbol	sha/603538
Website	https://www.menovopharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.74%
EV Earnings	141.35x
EV/EBIT	74.26x
EV/EBITDA	45.12x
EV/FCF	567.17x
EV/Sales	10.14x
FCF yield	0.19%
P/B ratio	6.04x
P/E ratio	127.42x
P/S ratio	9.64x
PE Ratio10 Y	50.25x
PE Ratio3 Y	83.05x
PE Ratio5 Y	60.6x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.65%
EBITDA Margin	22.19%
FCF margin	1.79%
Gross margin	33.97%
Gross Profit	CNY 531.4M
Gross Profit Growth	20.96%
Gross Profit Growth Q	5.43%
Gross Profit Growth3 Y	6.43%
Gross Profit Growth5 Y	4.85%
Net Income	CNY 112.2M
Net Income Growth	51.61%
Net Income Growth Q	46.84%
Net Income Growth Quarters	8%
Net Income Growth Years	2%
Net Income Growth3 Y	-25.11%
Net Income Growth5 Y	-7.17%
Pretax Margin	8.82%
Profit Margin	7.17%
Profit Per Employee	CNY 45,376
Profitable Years	15
ROA	2.89
Roa5y	2.07
ROCE	6.71
ROE	4.79
Roe5y	6.95
ROIC	5.76
Roic5y	4.82

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	356.59%
Cagr3y	45.54%
Cagr5y	17.88%
Div CAGR3	-32.83%
Div CAGR5	-24.1%
EPS Growth	47.57
EPS Growth Q	30
EPS Growth Quarters	8
EPS Growth Years	2
EPS Growth3 Y	-25.13
EPS Growth5 Y	-8.7
OCF Growth	24.02%
OCF Growth10 Y	0.5%
OCF Growth3 Y	-8.93%
OCF Growth5 Y	8.05%
Revenue Growth	12.82x
Revenue Growth Q	22.12x
Revenue Growth Quarters	1x
Revenue Growth Years	2x
Revenue Growth3 Y	9.15x
Revenue Growth5 Y	4.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.34
Assets	CNY 4.6B
Cash	CNY 641.5M
Current Assets	CNY 2B
Current Liabilities	CNY 1.4B
Debt	CNY 1.3B
Debt EBITDA	CNY 3.72
Debt Equity	CNY 0.52
Debt FCF	CNY 46.75
Equity	CNY 2.5B
Liabilities	CNY 2.1B
Long Term Assets	CNY 2.5B
Long Term Liabilities	CNY 689.3M
Net Cash	CNY -665.3M
Net Cash By Market Cap	CNY -4.41
Net Debt EBITDA	CNY 1.92
Net Debt Equity	CNY 0.27
Net Debt FCF	CNY 23.8
Tangible Book Value	CNY 2.2B
Tangible Book Value Per Share	CNY 9.8
WACC	4.21

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.45
Inventory Turnover	1.13
Net Working Capital	CNY 744.7M
Quick ratio	0.71
Working Capital	CNY 635.3M
Working Capital Turnover	CNY 3.22

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.74%
Dividend Growth	150%
Dividend Growth Years	1%
Dividend per share	CNY 0.05
Dividend Years	4
Dividend Yield	0.08%
Ex Div Date	2025-06-25
Last Dividend	CNY 0.05
Payout Frequency	Annual
Payout Ratio	23.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	356.12%
200-day SMA	26.85
3Y total return	208.38%
50-day SMA	39.15
50-day SMA vs 200-day SMA	50over200
5Y total return	127.62%
All Time High	70.39
All Time High Change	-9.5%
All Time High Date	2026-05-07
All Time Low	9.66
All Time Low Change	559.22%
All Time Low Date	2018-09-11
ATR	5.02
Beta	0.06
Beta1y	0.42
Beta2y	0.67
Ch YTD	231.1
High	64.35
High52	70.39
High52 Date	2026-05-07
High52ch	-9.5%
Low	57
Low52	13.55
Low52 Date	2025-05-15
Low52ch	370.11%
Ma50ch	62.7%
Price vs 200-day SMA	137.23%
RSI	65.34
RSI Monthly	83.49
RSI Weekly	92.96
Sharpe ratio	2.76x
Sortino ratio	5.53
Total Return	-2.66%
Tr YTD	231.1
Tr1m	62.05%
Tr1w	-7.01%
Tr3m	196.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 213.5M
Operating Income Growth	49.66
Operating Income Growth Q	25.18
Operating Income Growth3 Y	30.97
Operating Income Growth5 Y	6.32
Operating margin	13.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	177,494,722%
Net Borrowing	-70,849,237
Shares Insiders	5.86%
Shares Institutions	6.96%
Shares Out	236,637,097
Shares Qo Q	31.23%
Shares Yo Y	2.74%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 28M
Average Volume	62,293,768.45x
Bv Per Share	10.68
CAPEX	CNY -128.9M
Ch1m	62.05
Ch1w	-7.01
Ch1y	355
Ch3m	196.7
Ch3y	204.6
Ch5y	123.8
Ch6m	188.5
Change	3.33%
Change From Open	4.43
Close	61.65
Days Gap	-1.05
Depreciation Amortization	133,568,371
Dollar Volume	4,008,273,769.5
Earnings Date	2026-04-25
EBIT	CNY 213.5M
EBITDA	CNY 347.1M
EPS	CNY 0.5
F Score	8
FCF	CNY 28M
FCF EV Yield	0.18x
FCF Per Share	CNY 0.12
Financing CF	-99,580,800
Fiscal Year End	December
Founded	2,004
Graham Number	10.96029
Graham Upside	-82.79
Income Tax	CNY 22.6M
Investing CF	-68,406,916
Is Primary Listing	1
Last Earnings Date	2026-04-25
Last Report Date	2026-03-31
Last Split Date	2022-06-08
Last Split Type	Forward
Lynch Fair Value	CNY 2.5
Lynch Upside	-96.08
Ma150	27.17
Ma150ch	134.44%
Ma20	55.35
Ma20ch	15.08%
Net CF	-12,913,529
Next Earnings Date	2026-08-27
Open	61
P FCF Ratio	539.2
P OCF Ratio	96.09
Payment Date	2025-06-25
Position In Range	91.16
Ppne	1,788,055,220
Price Date	2026-05-08
Price EBITDA	CNY 43.43
Ptbv Ratio	6.91
Relative Volume	1.04x
Revenue	1,564,290,603x
Tax By Revenue	1.45x
Tax Rate	16.4%
Tr6m	188.5%
Volume	62,924,235

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/603538 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.1%

$0.05 annual per share

Payout ratio

+23.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-24.1%

1 consecutive years of growth

Total shareholder yield

-2.7%

Next ex-dividend date: 2025-06-25

Performance

SHA/603538 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/603538?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.0%

Share of float held by funds and institutions

Insider ownership

+5.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.7%

Negative means the company is buying back shares.

Technical

SHA/603538 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

65.3

Neutral momentum band

Price vs 200-day MA

+137.2%

50/200-day relationship not available

Beta (5Y)

0.06

Less volatile than the market

Sharpe ratio

2.76

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/603538

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/603538 stock rating?

sha/603538 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/603538 analysis?

The full report lives at /stocks/sha/603538/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/603538?

The latest report frames sha/603538 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/603538 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.